Atlas of Genetics and Cytogenetics in Oncology and Haematology


Home   Genes   Leukemias   Solid Tumours   Cancer-Prone   Deep Insight   Portal   Teaching

X Y 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 NA

GROUPE FRANCAIS DE CYTOGENETIQUE HEMATOLOGIQUE (GFCH)

[French Version]


Created in 1979 by J Tanzer, J Fraisse, R Berger, and H Van Den Berghe, the GFCH is part of the Société Française d'Hématologie (French society of haematology). In 1998, the GFCH federates 50 laboratories from France, Belgium, Switzerland, and Morocco. All GFCH works are cooperative, and its original working method (double revision of Cytogenetics files in regional and national workshops) is a guarantee of quality. The GFCH pubishes (see below) as a group, and has become a reference for the constitution of other similar groups in other European countries. There are 3 meetings a year, providing long acquaintances between hospital cytogeneticists, clinicians, and researchers. Our works have clinical, fundamental, and nosological values, as cytogenetics has provided deep insights in leukaemogenesis, and shows a renewed powerful potential with molecular cytogenetics. Subjects under study in 1998 are chronic lymphoid leukaemia, multiple myeloma, megakaryocytic leukaemias, chromosome 12 anomalies in myeloid malignancies, and chromosomes 5 and 7 rearrangements. The GFCH organizes thematic sessions at the congresses of the French society of haematology. A quality assessement scheme is under study since 1997.


Secretary


Pr Philippe BERNARD
Laboratoire d'Hématologie, Université Victor Segalen Bordeaux 2
146, rue Léo Saignat, 33076 Bordeaux Cedex
Tel : 05 57 57 15 81 Fax : 05 56 51 42 18
E-mail : Philippe.Bernard@hematologie.u-bordeaux2.fr


PUBLICATIONS LIST



STUDIES IN PROGRESS



Home Cytogenetic / clinical entities Solid Tumours Cancer-prone Diseases